Dr E. ABADIE is a physician. He has qualified in internal medicine, cardiology and endocrinology-diabetology in Paris university in 1981.
After having been resident and consultant in several Parisian hospitals, he joined the pharmaceutical industry, being international project manager at Roussel Uclaf, Director of development at Wellcome, and Director of Medical Affairs at SNIP. In this latter position, he represented the pharmaceutical industry in the main official committees at the Ministry of Health such as the Marketing Authorization, Transparency, Pharmacovigilance Committees.
In 1994, he joined the French Medicine Agency as Director of Therapeutic Evaluation Department. In 1995, he was appointed French member of the Efficacy Working Party, satellite of the CPMP. In this position he has been Rapporteur (and author) of several CPMP clinical guidelines in the field of diabetology, cardiology, osteoporosis, and central nervous system. In 1997, he became CPMP member. From 2001 until 2007, he has been vice chairman of the CHMP, and from June 2007 until April 2012 CHMP chairman. He has been also chairman of the Pharmacogenetics Working Party from 2001 until 2012. In the ICH process he has been the EU topic leader for the Common Technical Document, and ICH Steering Committee member until October 2007.
Since October 2012, he is consultant for the pharmaceutical and diagnostic industries.
He is the author of approximately 100 publications in clinical and medical science, member of the Editorial board of Cardiology (2005), and Associate Professor at the Tor Vergata University, Roma , in the Department of Epidemiology and Public Health, Liege University. He holds also a Master of Business Administration at the Centre de Perfectionnement des Affaires in Paris (1992). He has been nominated in 2003 Chevalier de la Légion d’Honneur.